UPDATE 1-Pfizer buys stake in French gene therapy firm Vivet
March 20, 2019 at 11:05 AM EDT
Pfizer Inc said on Wednesday it acquired a 15 percent stake in Vivet Therapeutics, as well as an exclusive option to fully acquire it, a deal that will give it access to the French company's experimental gene therapy for a rare genetic disorder called Wilson disease.